A COVID-19 variant that has led to a resurgence in cases in China has now been discovered in the United States according to the U.S. Centers for Disease Control and Prevention. Reports say that a CDC ...

Pfizer discontinues danuglipron after liver injury in trial patient Lilly and Novo Nordisk shares rise after Pfizer's decision Pfizer to focus on other obesity research April 14 (Reuters) - Pfizer ...

Matthew Herper covers medical innovation — both its promise and its perils. Capping more than two years of stock-gyrating drama, Pfizer said Monday that it would stop development of danuglipron ...